Green Cross Medical Science Statistics

Total Valuation

Green Cross Medical Science has a market cap or net worth of KRW 84.66 billion. The enterprise value is 112.29 billion.

Market Cap	84.66B
Enterprise Value	112.29B

Important Dates

The next estimated earnings date is Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Green Cross Medical Science has 21.71 million shares outstanding. The number of shares has increased by 13.23% in one year.

Current Share Class	n/a
Shares Outstanding	21.71M
Shares Change (YoY)	+13.23%
Shares Change (QoQ)	-2.71%
Owned by Insiders (%)	11.44%
Owned by Institutions (%)	n/a
Float	10.46M

Valuation Ratios

The trailing PE ratio is 563.87.

PE Ratio	563.87
Forward PE	n/a
PS Ratio	0.84
PB Ratio	2.18
P/TBV Ratio	2.22
P/FCF Ratio	298.85
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.56, with an EV/FCF ratio of 396.41.

EV / Earnings	747.94
EV / Sales	1.13
EV / EBITDA	24.56
EV / EBIT	142.68
EV / FCF	396.41

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.63.

Current Ratio	1.02
Quick Ratio	0.57
Debt / Equity	0.63
Debt / EBITDA	5.73
Debt / FCF	92.55
Interest Coverage	0.26

Financial Efficiency

Return on equity (ROE) is 0.32% and return on invested capital (ROIC) is 0.76%.

Return on Equity (ROE)	0.32%
Return on Assets (ROA)	0.53%
Return on Capital (ROIC)	0.76%
Revenue Per Employee	779.03M
Profits Per Employee	1.17M
Employee Count	128
Asset Turnover	1.08
Inventory Turnover	5.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.06% in the last 52 weeks. The beta is 0.51, so Green Cross Medical Science's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-11.06%
50-Day Moving Average	3,766.20
200-Day Moving Average	4,091.08
Relative Strength Index (RSI)	48.09
Average Volume (20 Days)	1,037,578

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Green Cross Medical Science had revenue of KRW 99.72 billion and earned 150.14 million in profits. Earnings per share was 6.97.

Revenue	99.72B
Gross Profit	13.68B
Operating Income	787.04M
Pretax Income	111.20M
Net Income	150.14M
EBITDA	4.57B
EBIT	787.04M
Earnings Per Share (EPS)	6.97

Full Income Statement

Balance Sheet

The company has 1.05 billion in cash and 26.22 billion in debt, giving a net cash position of -25.17 billion or -1,159.47 per share.

Cash & Cash Equivalents	1.05B
Total Debt	26.22B
Net Cash	-25.17B
Net Cash Per Share	-1,159.47
Equity (Book Value)	41.36B
Book Value Per Share	1,791.51
Working Capital	914.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.51 billion and capital expenditures -5.22 billion, giving a free cash flow of 283.28 million.

Operating Cash Flow	5.51B
Capital Expenditures	-5.22B
Free Cash Flow	283.28M
FCF Per Share	13.05

Full Cash Flow Statement

Margins

Gross margin is 13.72%, with operating and profit margins of 0.79% and 0.15%.

Gross Margin	13.72%
Operating Margin	0.79%
Pretax Margin	0.11%
Profit Margin	0.15%
EBITDA Margin	4.59%
EBIT Margin	0.79%
FCF Margin	0.28%

Dividends & Yields

Green Cross Medical Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.23%
Shareholder Yield	-13.23%
Earnings Yield	0.18%
FCF Yield	0.33%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Green Cross Medical Science has an Altman Z-Score of 2.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.32
Piotroski F-Score	n/a